Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 3/2008

01-09-2008 | REVIEW

Understanding and management of male breast cancer: a critical review

Authors: Kartikeya Pant, Udayan Dutta

Published in: Medical Oncology | Issue 3/2008

Login to get access

Abstract

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer cases worldwide. While treatments developed for women with breast cancer are often applied to treat men with breast cancer, however, lack of awareness of this disease leads to its detection at a later stage in men. This review discusses male breast cancer and draws comparisons with female breast cancer and discusses current treatments available to treat this disease. It is believed that this review shall provide concise and relevant information increasing the awareness of issues revolving around male breast cancer (MBC).
Literature
1.
Ravandi-Kashani F, Hayes TG. Male breast cancer: a review of the literature. Eur J Cancer 1998;34:1341–7.PubMedCrossRef
2.
Giordano Sharon H, Buzdar Aman U, Hortobagyi Gabriel N. Breast cancer in men. Ann Intern Med 2002;137:678–87.PubMed
3.
Arnould N, Pouget O, Gharbi M, Brettes JP. Breast cancer in men: are there similarities with breast cancer in women? Gynecol Obstet Fertil 2006;34:413–9.PubMedCrossRef
4.
Giordano Sharon H. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471–9.PubMedCrossRef
5.
Iredale R, Brain K, Williams B, France E, Gray J. The experiences of men with breast cancer in the United Kingdom. Eur J Cancer 2006;42:334–41.PubMedCrossRef
6.
Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H. Male breast cancer in Iceland. Int J Cancer 1996;65:446–9.PubMedCrossRef
7.
Giordano Sharon H, Cohen Deborah S, Buzdar Aman U, Perkins G, Hortobagyi Gabriel N. Breast carcinoma in men: a population-based study. Cancer 2004;101:51–7.PubMedCrossRef
8.
Joshi MG, Lee AKC, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996;77:490–8.PubMedCrossRef
9.
Stratton MR, Ford D, Neuhasen S, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994;7:103–7.PubMedCrossRef
10.
Karhu R, Laurila E, Kallioniemi A, Syrjakoski K. Large genomic BRCA2 rearrangements and male breast cancer. Cancer Detect Prev 2006;30:530–4.PubMedCrossRef
11.
Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001;68:410–9.PubMedCrossRef
12.
Chakrabarti J, Rampaul RS, Guevara C, et al. The pathology of male breast cancer. Int J Cancer Prev 2005;2:213–23.
13.
Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev 2006;15:39–44.PubMedCrossRef
14.
15.
Simpson E, Rubin G, Clyne C, et al. Local estrogen biosynthesis in males and females. Endocr Relat Cancer 1999;6:131–7.PubMedCrossRef
16.
Shozu M, Simpson ER. Aromatase expression of human osteoblast-like cells. Mol Cell Endocrinol 1998;139:117–29.PubMedCrossRef
17.
Shozu M, Zhao Y, Simpson ER. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene. Endocrinology 1997;138:5125–35.PubMedCrossRef
18.
Simpson ER, Zhao Y, Agarwal VR, et al. Aromatase expression in health and disease. Recent Prog Horm Res 1997;52:185–213;discussion 213–4.PubMed
19.
Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab 1997;82:70–4.PubMedCrossRef
20.
Zhao Y, Agarwal VR, Mendelson CR, Simpson ER. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 1996;137:5739–42.PubMedCrossRef
21.
Tsai-Morris CH, Aquilano DR, Dufau ML. Cellular localization of rat testicular aromatase activity during development. Endocrinology 1985;116:38–46.PubMedCrossRef
22.
Nitta H, Bunick D, Hess RA, et al. Germ cells of the mouse testis express P450 aromatase. Endocrinology 1993;132:1396–401.PubMedCrossRef
23.
Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 1974;38:476–9.PubMed
24.
de Jong PC, van de Ven J, Nortier HW, et al. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole. Cancer Res 1997;57:2109–11.PubMed
25.
Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer 1999;85:629–39.PubMedCrossRef
26.
27.
Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31A:1960–4.PubMedCrossRef
28.
Gennari R, Curigliano G, Jereczek-Fossa Barbara A, et al. Male breast cancer: a special therapeutic problem. Anything new? Int J Oncol 2004;24:663–70.PubMed
29.
Ben Dhiab T, Bouzid T, Gamoudi A, et al. Male breast cancer: about 123 cases collected at the Institute Salah-Azaiz of Tunis from 1979 to 1999. Bull Cancer 2005;92:281–5.PubMed
30.
Agrawal A, Ayantunde AA, Rampaul R, Robertson JFR. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007;103:11–21.PubMedCrossRef
31.
Ribiero G. Male breast carcinoma: a review of 301 cases from the Christie Hospital and Holt Radium Institute, Manchester. Br J Cancer 1985;51:115–9.
32.
Nahleh ZA. Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev 2006;32:101–5.PubMedCrossRef
33.
34.
Turner KJ, Morley M, Atanassova N, Swanston ID, Sharpe RM. Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. J Endocrinol 2000;164:225–38.PubMedCrossRef
35.
Giordano Sharon H, Duan Z, Kuo Y-F, Hortobagyi Gabriel N, Goodwin James S. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006;24:2750–6.PubMedCrossRef
36.
Giordano Sharon H, Perkins George H, Broglio K, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104:2359–64.PubMedCrossRef
37.
38.
Bagley CS, Wesley MN, Young RC, Lippman ME. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987;10:55–60.PubMedCrossRef
39.
Patel HZ II, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer 1989;64:1583–5.PubMedCrossRef
40.
Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;365:1687–717.CrossRef
41.
Kiss A, Meryn S. Effect of sex and gender on psychosocial aspects of prostate and breast cancer. BMJ 2001;323:1055–8.PubMedCrossRef
42.
Moynihan C. Theories in health care and research: theories of masculinity. BMJ 1998;317:1072–5.PubMed
43.
Lee C, Owens RG. Issues for psychology of men’s health. J Health Psychol 2002;7:209–17.CrossRef
Metadata
Title
Understanding and management of male breast cancer: a critical review
Authors
Kartikeya Pant
Udayan Dutta
Publication date
01-09-2008
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 3/2008
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-007-9034-y

Other articles of this Issue 3/2008

Medical Oncology 3/2008 Go to the issue

Original Paper

Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases

Original Paper

Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene

Original Paper

Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture

Original Paper

Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study

Original Paper

Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer

Original Paper

Oral premedication for the prevention of hypersensitivity reactions to paclitaxel
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits